These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 18989125)

  • 1. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS; Clarkson TB; Notelovitz M
    Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE
    MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where are we with postmenopausal hormone therapy in 2005?
    Lam PM; Chung TK; Haines C
    Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study.
    Sveinsdóttir H; Olafsson RF
    J Adv Nurs; 2006 Jun; 54(5):572-84. PubMed ID: 16722955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 9. Women's health. The vanishing promises of hormone replacement.
    Enserink M
    Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract]   [Full Text] [Related]  

  • 10. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 11. Indications for hormone therapy: the post-Women's Health Initiative era.
    Reed SD; Newton KM; Lacroix AZ
    Endocrinol Metab Clin North Am; 2004 Dec; 33(4):691-715. PubMed ID: 15501641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.
    U.S. Preventive Services Task Force
    Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
    Peeyananjarassri K; Baber R
    Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in utilisation of hormone replacement therapy in Australia following publication of the findings of the Women's Health Initiative.
    Main P; Robinson M
    Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):861-8. PubMed ID: 18504768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHI risks: any relevance to menopause management?
    Burger HG
    Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of hormone replacement therapy in the Hong Kong public health sector after the Women's Health Initiative trial.
    Leung KY; Ling M; Tang GW
    Maturitas; 2005; 52(3-4):277-85. PubMed ID: 15950409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls of the WHIs: Women's Health Initiative.
    Mastorakos G; Sakkas EG; Xydakis AM; Creatsas G
    Ann N Y Acad Sci; 2006 Dec; 1092():331-40. PubMed ID: 17308158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.